Safety and tolerability of first‐line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma

Abstract Background Advanced or metastatic esophageal squamous cell carcinoma (ESCC) is associated with poor prognosis; new first‐line systemic treatment options are needed. Combining immuno‐oncology therapies with standard chemotherapy may represent a promising approach for the treatment of solid t...

Full description

Bibliographic Details
Published in:	Cancer Medicine
Main Authors:	Dae Ho Lee, Hye Ryun Kim, Bhumsuk Keam, Ken Kato, Yasutoshi Kuboki, Haiyan Gao, Alejandro Yovine, Scott H. Robbins, Myung‐Ju Ahn
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Subjects:	chemotherapy clinical trials esophageal squamous cell immunology
Online Access:	https://doi.org/10.1002/cam4.6260

Similar Items

The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective study
by: Ruotong Wang, et al.
Published: (2024-09-01)

Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis
by: Dae Gon Ryu, et al.
Published: (2024-09-01)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
by: Xianfeng Li, et al.
Published: (2023-01-01)

Esophageal squamous cell carcinoma presenting as a submucosal tumor
by: Lin Yang, et al.
Published: (2023-08-01)

Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study
by: Xiaoyou Li, et al.
Published: (2025-04-01)

Defining conversion therapy for esophageal squamous cell carcinoma
by: Satoru Matsuda, et al.
Published: (2023-01-01)

Clinical outcomes of esophageal squamous cell carcinoma in patients aged over 80 years
by: Dae Gon Ryu, et al.
Published: (2025-03-01)

A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract
by: Michal Sarfaty, et al.
Published: (2021-02-01)

Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females
by: Motomitsu Fukuhara, et al.
Published: (2024-02-01)

Endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in patients with cirrhosis and esophageal varices
by: Tomoaki Mochimaru, et al.
Published: (2023-04-01)

Predictive factors for esophageal stenosis in patients receiving prophylactic steroid therapy after endoscopic submucosal dissection for esophageal squamous cell carcinoma
by: Junichi Mizuno, et al.
Published: (2024-01-01)

Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma
by: Yuh Baba, et al.
Published: (2017-12-01)

Comparison of the Clinical Outcomes of Esophagectomy and Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
by: Myung Hun Lee, et al.
Published: (2024-03-01)

Differential safety profiles of durvalumab monotherapy and durvalumab in combination with tremelimumab in adult patients with advanced cancers
by: Mayur Patel, et al.
Published: (2025-05-01)

Inducing multiple antibodies to treat squamous cell esophageal carcinoma
by: Isamu Hoshino, et al.
Published: (2020-10-01)

Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya
by: Natalie R. Pritchett, et al.
Published: (2017-12-01)

Prognostic factors for esophageal respiratory fistula in unresectable esophageal squamous cell carcinoma treated with radiotherapy
by: Jia-Chao Qi, et al.
Published: (2024-07-01)

Characteristics of Esophageal Squamous Cell Carcinomas Based on Circumferential Localization
by: Natsuki Ishida, et al.
Published: (2024-12-01)

Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma
by: Nobukazu Hokamura, et al.
Published: (2024-09-01)

Esophageal Squamous Cell Carcinoma with Marked Eosinophil Infiltration
by: Minoru Fukuchi, et al.
Published: (2011-11-01)

Case Report: Esophageal squamous cell carcinoma in a 13-year-old boy with a history of esophageal atresia with tracheoesophageal fistula
by: B. Bernar, et al.
Published: (2024-10-01)

Investigating esophageal sarcomatoid carcinoma and its comparison with esophageal squamous cell carcinoma on clinicopathological characteristics, prognosis, and radiomics features: a retrospective study
by: Binbin Hu, et al.
Published: (2024-07-01)

Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China
by: Shu Huang, et al.
Published: (2025-02-01)

Esophageal Pleural Fistula in Esophageal Squamous Cell Carcinoma: A Diagnostic Challenge
by: Naghmeh Salarieh, et al.
Published: (2023-08-01)

Schwann cell reprogramming and Esophageal squamous cell carcinoma: analysis of transcriptome data
by: Roberta Karolline de Souza Lima, et al.
Published: (2024-12-01)

Endoscopic Evaluation and Management of Superficial Esophageal Squamous Cell Carcinoma
by: Priscilla Lopez, et al.
Published: (2024-09-01)

The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based study
by: Shalika Bohingamu Mudiyanselage, et al.
Published: (2024-12-01)

Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021
by: Pietari Junkala, et al.
Published: (2025-08-01)

Nomograms for predicting the prognosis in multiple primary esophageal squamous cell carcinoma
by: Kexi Wang, et al.
Published: (2024-12-01)

Grading criteria for venous invasion in thoracic esophageal squamous cell carcinoma
by: An Wang, et al.
Published: (2023-04-01)

Truth telling for patients with esophageal squamous cell carcinoma in Henan, China
by: Lian-Qun Zhang, et al.
Published: (2017-01-01)

Esophageal Squamous Cell Carcinoma With Pancreatic Metastasis: A Case Report
by: Abbas Alibakhshi, et al.
Published: (2011-11-01)

Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study
by: Yan Chen, et al.
Published: (2018-12-01)

Diffuse Esophageal Squamous Papillomatosis: A Rare Disease Associated with Acanthosis Nigricans and Tripe Palms
by: Tanyaporn Chantarojanasiri, et al.
Published: (2020-12-01)

Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma
by: Zachary A. Cooper, et al.
Published: (2025-03-01)

Incorporation of PET Metabolic Parameters With Clinical Features Into a Predictive Model for Radiotherapy-Related Esophageal Fistula in Esophageal Squamous Cell Carcinoma
by: Kaixin Li, et al.
Published: (2022-02-01)

Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?
by: D. A. Chichevatov, et al.
Published: (2024-05-01)

Profile of Nivolumab in the Treatment of Resected Esophageal Squamous Cell Carcinoma: A Review of the Clinical Data
by: Kim Y, et al.
Published: (2023-05-01)

Definitive Chemoradiation with Concurrent Weekly Cisplatin in the Treatment of Esophageal Squamous Cell Carcinoma – A Simplistic Approach
by: Imtiaz Ahmed, et al.
Published: (2021-05-01)

TP53 Mutations in Esophageal Squamous Cell Carcinoma
by: Leqi Zhong, et al.
Published: (2023-09-01)